regeneron enters into asset purchase agreement to acquire 23andme for 256 million plans to maintain consumer genetics business and advance shared goals of improving human health an
Monday, May 19, 2025 1 min read
Key Takeaway: regeneron enters into asset purchase agreement to acquire 23andme for 256 million plans to maintain consumer genetics business and advance shared goals of improving human health an
Full Press Release Details
regeneron enters into asset purchase agreement to acquire 23andme for 256 million plans to maintain consumer genetics business and advance shared goals of improving human health an.